Accuray to Report Fourth Quarter Fiscal 2024 Financial Results on August 14, 2024
Accuray Incorporated (NASDAQ: ARAY) has announced it will report its fourth quarter fiscal 2024 financial results on August 14, 2024. The company will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on the same day. Investors can access the call via phone or a live webcast from the company's website. A replay of the call will be available for one week after the event.
Accuray is a Madison, Wisconsin-based company that specializes in innovative radiation therapy solutions for oncology and neuro-radiosurgery. The company focuses on developing technologies to treat complex cases while simplifying common treatments, aiming to improve patient outcomes and quality of life.
Accuray Incorporated (NASDAQ: ARAY) ha annunciato che riferirà i suoi risultati finanziari del quarto trimestre dell'anno fiscale 2024 il 14 agosto 2024. L'azienda terrà una conference call alle 13:30 PT/16:30 ET lo stesso giorno. Gli investitori potranno partecipare alla chiamata tramite telefono o tramite una diretta web dal sito dell'azienda. Una registrazione della chiamata sarà disponibile per una settimana dopo l'evento.
Accuray è un'azienda con sede a Madison, Wisconsin, specializzata in soluzioni innovative di terapia radiante per oncologia e neurochirurgia radioterapica. L'azienda si concentra sullo sviluppo di tecnologie per trattare casi complessi, semplificando al contempo i trattamenti comuni, con l'obiettivo di migliorare i risultati per i pazienti e la qualità della vita.
Accuray Incorporated (NASDAQ: ARAY) ha anunciado que informará sobre sus resultados financieros del cuarto trimestre del año fiscal 2024 el 14 de agosto de 2024. La compañía llevará a cabo una llamada de conferencia a la 1:30 p.m. PT/4:30 p.m. ET el mismo día. Los inversores podrán acceder a la llamada por teléfono o a través de una transmisión en vivo desde el sitio web de la empresa. Una grabación de la llamada estará disponible durante una semana después del evento.
Accuray es una empresa con sede en Madison, Wisconsin, que se especializa en soluciones innovadoras de terapia de radiación para oncología y neurocirugía radioterapéutica. La empresa se centra en desarrollar tecnologías para tratar casos complejos mientras simplifica tratamientos comunes, con el objetivo de mejorar los resultados para los pacientes y la calidad de vida.
Accuray Incorporated (NASDAQ: ARAY)는 2024 회계연도 4분기 재무 결과를 2024년 8월 14일 보고할 것이라고 발표했습니다. 회사는 같은 날 오후 1시 30분 PT/오후 4시 30분 ET에 컨퍼런스 콜을 개최합니다. 투자자들은 회사 웹사이트에서 전화 또는 생중계를 통해 이 전화를 들을 수 있습니다. 통화의 재생본은 이벤트 후 1주일 동안 제공됩니다.
Accuray는 위스콘신주 매디슨에 본사를 둔 회사로, 종양학 및 신경 방사선 수술을 위한 혁신적인 방사선 치료 솔루션을 전문으로 합니다. 이 회사는 복잡한 사례를 치료하는 기술을 개발하는 데 중점을 두며, 동시에 일반 치료를 단순화하여 환자의 결과와 삶의 질을 향상시키는 것을 목표로 하고 있습니다.
Accuray Incorporated (NASDAQ: ARAY) a annoncé qu'il publiera ses résultats financiers du quatrième trimestre de l'exercice 2024 le 14 août 2024. L'entreprise organisera une conférence téléphonique à 13h30 PT/16h30 ET le même jour. Les investisseurs pourront accéder à cet appel par téléphone ou via un webinaire en direct sur le site de l'entreprise. Un enregistrement de l'appel sera disponible pendant une semaine après l'événement.
Accuray est une entreprise basée à Madison, Wisconsin, qui se spécialise dans des solutions innovantes de radiothérapie pour l'oncologie et la neurochirurgie radiologique. L'entreprise se concentre sur le développement de technologies pour traiter des cas complexes tout en simplifiant les traitements courants, dans le but d'améliorer les résultats pour les patients et leur qualité de vie.
Accuray Incorporated (NASDAQ: ARAY) hat angekündigt, dass es am 14. August 2024 seine Finanzergebnisse für das vierte Quartal des Geschäftsjahres 2024 bekannt geben wird. Das Unternehmen wird am selben Tag um 13:30 Uhr PT/16:30 Uhr ET eine Telefonkonferenz veranstalten. Investoren können den Anruf entweder telefonisch oder über ein Live-Streaming auf der Website des Unternehmens verfolgen. Eine Aufnahme des Anrufs wird eine Woche nach der Veranstaltung verfügbar sein.
Accuray ist ein Unternehmen mit Sitz in Madison, Wisconsin, das sich auf innovative Strahlentherapielösungen für Onkologie und Neuro-Radiosurgie spezialisiert hat. Das Unternehmen konzentriert sich darauf, Technologien zur Behandlung komplexer Fälle zu entwickeln, während es gleichzeitig gängige Behandlungen vereinfacht, um die Ergebnisse für die Patienten und die Lebensqualität zu verbessern.
- None.
- None.
The conference call dial-in numbers are (833) 316-0563 (
A live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the first quarter of fiscal 2025.
About Accuray
Accuray Incorporated (Nasdaq: ARAY) is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in
Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-fourth-quarter-fiscal-2024-financial-results-on-august-14-2024-302210837.html
SOURCE Accuray Incorporated
FAQ
When will Accuray (ARAY) report its Q4 fiscal 2024 financial results?
How can investors access Accuray's (ARAY) Q4 2024 earnings call?
What is the main focus of Accuray's (ARAY) business?